First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer
植物制剂PHY906联合卡培他滨作为二线疗法治疗晚期胰腺癌患者的首个人体II期临床试验
期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-013-2359-7
Saif, Muhammad Wasif; Li, Jia; Lamb, Lynne; Kaley, Kristin; Elligers, Kyle; Jiang, Zaoli; Bussom, Scott; Liu, Shwu-Huey; Cheng, Yung-Chi
